Discontinuation report VIDEX EC
Report ID | 55446 |
Drug Identification Number | 02244598 |
Brand name | VIDEX EC |
Common or Proper name | DIDANOSINE |
Company Name | BRISTOL-MYERS SQUIBB CANADA |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | DIDANOSINE |
Strength(s) | 250MG |
Dosage form(s) | CAPSULE (ENTERIC-COATED) |
Route of administration | ORAL |
Packaging size | 1 BTL x 30 |
ATC code | J05AF |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2020-03-31 |
Actual discontinuation date | 2020-03-31 |
Remaining supply date | 2020-03-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | All strengths are being deleted. |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2344 BOUL. ALFRED-NOBEL, SUITE 300 ST-LAURENT, QUEBEC CANADA H4S 0A4 |
Company contact information | For more information please contact the Customer Service Desk at 1-800-267-0005 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-07-11 | English | Compare |
v2 | 2018-07-11 | French | Compare |
v3 | 2020-04-01 | English | Compare |
v4 | 2020-04-01 | French | Compare |
Showing 1 to 4 of 4